Div Com reviews measures for establishing Silk cluster


SRINAGAR:- Divisional Commissioner Kashmir, Dr. Asgar Hassan Samoon today convened a meeting to review the measures being taken for the establishment of Silk cluster at Solina Srinagar under the MSME, scheme.

The meeting was attended by the Deputy Commissioner Srinagar, Director Sericulture, Deputy General Manager NABARD, Director MSME (Dev Institute) Jammu, General Manager SIDCO besides other officers of the concerned departments.

Threadbare discussions were held during the meeting for the production of silk cocoons and identifying of 20 kanals of land in Solina area for the establishment of silk cluster.

The Divisional Commissioner emphasized the need for overall development of Sericulture and Silk Industry with special focus on cocoon sector, silk cocoon production and productivity, besides dissemination of new technology methods and adopting cluster approach.

Dr Samoon said that the latest production technological inputs, new mulberry and silk worm varieties are slated to be introduced to improve silk trade in the valley. He further said that the cocoon production in Karnataka and other cities of India has become most profitable job and a large population is associated with the trade. He said J&K has vast potential to boost this industry and concerned departments should work with added zeal to give fillip to this trade which will provide ample oppurtunities of employment to the youth.

Prices of 56 drugs to come down; NPPA fixes ceiling rates

New Delhi: Prices of  56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, may come down with the government fixing their ceiling prices under the drug pricing control mechanism.

The companies whose drugs are included for price fixation include Abbott Healthcare, Cipla, Lupin, Alembic, Alkem Laboratories, Novartis, Biocon, Intas Pharmaceuticals, Hetero Healthcare and erstwhile Ranbaxy (now Sun Pharmaceutical Industries), according to notifications by the National Pharmaceutical Pricing Authority (NPPA).

The authority has “fixed/revised ceiling prices” of a total of 56 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016, and retail prices of eight formulations under DPCO, 2013, according to the notifications.

“The manufacturers not complying with the ceiling price and notes specified herein-above shall be liable to deposit the overcharged amount along with interest thereon…,” the notification said.

The government fixes the prices of essential drugs based on the simple average of all medicines in a particular therapeutic segment, having sales of more than 1 per cent.

Companies are allowed to hike prices of such drugs by up to 10 per cent in a year. The government had notified DPCO, 2013, which covers 680 formulations, with effect from May 15, 2014, replacing the 1995 order that regulated prices of only 74 bulk drugs.

Set up in 1997, NPPA has been entrusted with the task of fixation/revision of prices of pharma products, enforcement of provisions of the Drugs (Prices Control) Order and monitoring of prices of controlled and decontrolled drugs.PTI

Aircel adds ‘extra’ joy to Ramzaan festivities

Be Part of Quality Journalism

Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast.



Observer News Service

Leave a Reply

Your email address will not be published.